本頁面由Tiger Trade Technology Pte. Ltd.提供服務

XILIO THERAPEUTICS, INC.

0.7181
-0.0141-1.93%
盤前0.71810.00000.00%08:00 EST
成交量:50.60萬
成交額:36.78萬
市值:3,770.05萬
市盈率:-0.64
高:0.7320
開:0.7300
低:0.7109
收:0.7322
52周最高:1.70
52周最低:0.6150
股本:5,250.03萬
流通股本:2,343.38萬
量比:0.60
換手率:2.16%
股息:- -
股息率:- -
每股收益(TTM):-1.1285
每股收益(LYR):-1.0884
淨資產收益率:-908.28%
總資產收益率:-26.26%
市淨率:-4.66
市盈率(LYR):-0.66

資料載入中...

2024/04/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/04/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/01

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/10

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/09/05

重要事件披露

Form 8-K - Current report